Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3150 of 3284 entries
View as:

[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL

Phase: N/A Priority: Normal
NCT ID: NCT01408303 Org: User:
Start: 08/31/11 End: 06/30/12 Due: 06/30/13

AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies

Phase: N/A Priority: Normal
NCT ID: NCT03313557 Org: User:
Start: 10/27/17 End: 05/17/19 Due: 05/17/20

Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT02157376 Org: User:
Start: 07/31/14 End: 02/29/16 Due: 02/28/17

Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria

Phase: N/A Priority: Normal
NCT ID: NCT02733601 Org: User:
Start: 05/29/16 End: 03/31/22 Due: 03/31/23

Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT05470725 Org: User:
Start: 01/12/21 End: 04/30/21 Due: 04/30/22

A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01016951 Org: User:
Start: 12/31/09 End: 06/30/10 Due: 06/30/11

Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00683618 Org: User:
Start: 05/31/08 End: 07/31/09 Due: 07/31/10

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02599714 Org: User:
Start: 12/07/15 End: 11/23/23 Due: 11/23/24

Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00771069 Org: User:
Start: 11/30/08 End: 03/31/09 Due: 03/31/10

Faslodex Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01501266 Org: User:
Start: 02/29/12 End: 01/31/15 Due: 01/31/16

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

Phase: N/A Priority: Normal
NCT ID: NCT00503061 Org: User:
Start: 06/30/07 End: 05/31/10 Due: 05/31/11

Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01232322 Org: User:
Start: 10/31/06 End: 07/31/11 Due: 07/31/12

Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02400333 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

Phase: N/A Priority: Normal
NCT ID: NCT02143466 Org: User:
Start: 08/05/14 End: 12/31/25 Due: 12/31/26

Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00503412 Org: User:
Start: 11/30/05 End: 05/31/06 Due: 05/31/07

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

Phase: N/A Priority: Normal
NCT ID: NCT00926731 Org: User:
Start: 06/30/09 End: 05/31/11 Due: 05/31/12

A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC Region

Phase: N/A Priority: Normal
NCT ID: NCT06039683 Org: User:
Start: 12/31/22 End: 07/04/24 Due: 07/04/25

A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.

Phase: N/A Priority: Normal
NCT ID: NCT01202604 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients

Phase: N/A Priority: Normal
NCT ID: NCT02430493 Org: User:
Start: 05/28/15 End: 03/29/17 Due: 03/29/18

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib

Phase: N/A Priority: Normal
NCT ID: NCT01725230 Org: User:
Start: 11/30/12 End: 01/31/13 Due: 01/31/14

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00673387 Org: User:
Start: 04/30/08 End: 10/31/09 Due: 10/31/10

A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.

Phase: N/A Priority: Normal
NCT ID: NCT03772223 Org: User:
Start: 01/21/19 End: 05/10/19 Due: 05/10/20

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00753545 Org: User:
Start: 08/28/08 End: 10/12/23 Due: 10/12/24

C.Difficile Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT06277999 Org: User:
Start: 04/22/24 End: 12/17/24 Due: 12/17/25

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Phase: N/A Priority: Normal
NCT ID: NCT05459688 Org: User:
Start: 04/06/22 End: 11/07/23 Due: 11/07/24